title: Recurrent priapism during treatment with clozapine, quetiapine and haloperidol.
abstract: The following is a letter to the editor that represents a case of recurrent priapism. The patient received clozapine, quetiapine and haloperidol and had the adverse reaction of priapism, one episode of which required surgical intervention. This case highlights the need for physicians to be aware of the potential for this serious adverse effect and to be especially mindful to carefully monitor those patients who have already had one episode of priapism as they may be at risk for recurrence.
authors: Hygiea
authors: H
authors: Casiano
authors: Daniel
authors: D
authors: Globerman
authors: Murray W
authors: MW
authors: Enns
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003024:Clozapine / Q000009:adverse effects*; D003987:Dibenzothiazepines / Q000009:adverse effects*; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D008297:Male; D011317:Priapism / Q000139:chemically induced*; D000069348:Quetiapine Fumarate; D012008:Recurrence
chemical_list: D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate; D003024:Clozapine; D006220:Haloperidol